We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

191 hedge funds and large institutions have $446M invested in Sage Therapeutics in 2025 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

79% more call options, than puts

Call options by funds: $7.52M | Put options by funds: $4.19M

8% more capital invested

Capital invested by funds: $411M → $446M (+$34.2M)

7% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 55

10% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 42

3% less funds holding

Funds holding: 197 → 191 (-6)

6.13% less ownership

Funds ownership: 84.15% → 78.02% (-6.1%)

Holders
191
Holders Change
-6
Holders Change %
-3.05%
% of All Funds
2.51%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
38
Increased
59
Reduced
55
Closed
42
Calls
$7.52M
Puts
$4.19M
Net Calls
+$3.32M
Net Calls Change
+$3.85M

Top Buyers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
+$11.8M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$10.3M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$10.1M
4
AAM
Alpine Associates Management
Florida
+$9.37M
5
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$7.96M

Top Sellers

Rank Fund Capital Flow
1
CP
Caligan Partners
New York
-$24.3M
2
TAL
TIG Advisors LLC
New York
-$19.5M
3
DTC
Deep Track Capital
Connecticut
-$16.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$13.3M
5
BFM
Boothbay Fund Management
New York
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$4.73M +$596K +81,054 +19%
Northern Trust
27
Northern Trust
Illinois
$4.22M -$40.2K -5,472 -1%
Charles Schwab
28
Charles Schwab
California
$4.18M +$88.8K +12,070 +3%
GCL
29
Glazer Capital LLC
New York
$4.02M +$3.24M +441,108 New
OAC
30
OMERS Administration Corp
Ontario, Canada
$3.87M +$3.12M +424,300 New
AA
31
AQR Arbitrage
Connecticut
$3.73M +$3.01M +409,055 New
MAM
32
Monaco Asset Management
Monaco
$3.34M -$552K -75,000 -17%
HF
33
HRT Financial
New York
$3.02M +$1.33M +180,342 +120%
ECM
34
Eisler Capital Management
United Kingdom
$3.01M +$1.18M +160,150 +94%
YIH
35
Y-Intercept (HK)
Hong Kong
$2.77M +$2.24M +303,888 New
BCM
36
BCK Capital Management
Connecticut
$2.71M +$2.18M +297,040 New
JF
37
Jump Financial
Illinois
$2.64M +$741K +100,743 +53%
Two Sigma Investments
38
Two Sigma Investments
New York
$2.44M -$665K -90,378 -25%
Federated Hermes
39
Federated Hermes
Pennsylvania
$2.25M -$6.96M -945,685 -79%
GCIA
40
Gabelli & Co Investment Advisers
New York
$2.05M +$1.65M +224,450 New
TI
41
Trexquant Investment
Connecticut
$2.03M -$3.02M -410,504 -65%
Deutsche Bank
42
Deutsche Bank
Germany
$1.97M -$59.4K -8,077 -4%
GF
43
Gabelli Funds
New York
$1.83M +$1.48M +200,777 New
Invesco
44
Invesco
Georgia
$1.83M +$278K +37,838 +23%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$1.81M -$928K -126,200 -39%
SFI
46
Susquehanna Fundamental Investments
Pennsylvania
$1.79M -$112K -15,279 -7%
CSS
47
Cubist Systematic Strategies
Connecticut
$1.75M +$1.41M +192,258 New
Verition Fund Management
48
Verition Fund Management
Connecticut
$1.68M +$91.4K +12,422 +7%
Bank of New York Mellon
49
Bank of New York Mellon
New York
$1.67M +$75.6K +10,281 +6%
YCM
50
Yakira Capital Management
Connecticut
$1.67M +$1.34M +182,634 New
1
2
3 4 5

SAGE Hedge Fund Activity: Q2 2025 in Review

191 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q2 2025, worth a combined $446M — up 8.3% from $411M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of SAGE and 38 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 59 added.

The largest buyer was Madison Avenue Partners, adding an estimated $11.8M. The largest seller was Caligan Partners, exiting entirely with an estimated $24.3M sold.

  • 191 institutional investors held Sage Therapeutics (SAGE) as of Q2 2025, down from 197 in Q1 2025.
  • Funds reported $446M of Sage Therapeutics stock for Q2 2025, up 8.3% quarter-over-quarter.
  • 38 funds opened new Sage Therapeutics positions in Q2 2025 and 42 closed out, a net change of -4 holders.
  • The largest Sage Therapeutics buyer in Q2 2025 was Madison Avenue Partners, an estimated $11.8M added.
  • The largest Sage Therapeutics seller in Q2 2025 was Caligan Partners, an estimated $24.3M sold.

Based on aggregated 13F filings for Q2 2025.